Exercise programs for cancer survivors in rural areas
Official title: Project EXCEL: Dissemination, Implementation, and Effectiveness of the Exercise Oncology Survivorship Partnership Model - Reaching Rural Cancer Survivors to Enhance Quality of Life
Run by University of Calgary · NCT04478851 · Data updated 2026-11-12
This study is testing community and online exercise programs for cancer survivors in rural areas to see if they can help improve their quality of life and encourage long-term fitness habits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Locations | 3 sites (Calgary, Alberta and 2 other locations) |
| Status | Recruiting |
| Started | September 2, 2020 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | March 31, 2022 |
| Trial ID | NCT04478851 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include cancer survivors over 18 years old who can participate in mild levels of activity and have had treatment within the last five years.
✕Probably not a fit
Patients who are unable to participate in exercise or do not have access to the internet for online programs may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Project EXCEL aims to provide community and online exercise programs tailored for rural and underserved cancer survivors. The initiative focuses on promoting lifelong exercise habits as a self-management strategy to enhance quality of life. Over five years, the project will implement and evaluate an Exercise Oncology Survivorship partnership model, creating sustainable pathways between cancer care clinics and trained fitness professionals. Participants will be screened for exercise safety and will engage in group exercise classes designed to meet their specific needs.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life for cancer survivors living in rural and underserved areas.
How similar studies have gone: Other studies have shown success in implementing exercise programs for cancer survivors, but this approach specifically targets rural and underserved populations, making it a novel initiative.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * have a diagnosis of cancer * are over the age of 18 years * are able to participate in mild levels of activity * are about to have treatment, are currently having treatment, or have had cancer treatment within the last 5 years * can read/write in English * can access online programs, if necessary, to participate in the exercise programs. Exclusion Criteria: * unable to read/write in English * are unable to participate in exercise * for online programs, do not have internet or computer access
Where it's running
-
Health and Wellness Lab, University of Calgary
Calgary, Alberta, Canada Recruiting -
University of Alberta
Edmonton, Alberta, Canada Not yet recruiting -
Dalhousie University
Halifax, Nova Scotia, Canada Not yet recruiting
Study contacts
- Principal investigator: Nicole Culos-Reed, PhD — University of Calgary
- Study coordinator: Nicole Culos-Reed, PhD
- Email: nculosre@ucalgary.ca
- Phone: +1 (403) 220-7540
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual exercise program to preserve function and prevent disability during chemotherapy
This trial tests whether supervised resistance sessions by video plus short home aerobic workouts help adults 18–64 maintain strength and stay active while receiving curative-intent chemotherapy.
-
Using brodalumab to treat immune-related side effects from cancer therapy
This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.
-
Testing MDX2001 for advanced solid tumors
This study is testing a new drug called MDX2001 to see if it can safely help people with advanced solid tumors like breast or colon cancer.
-
Using blood tests to assess early treatment response in cancer patients
This study is testing if blood tests that look for cancer DNA can help doctors see how well treatment is working for patients with different types of solid tumors.
-
Digital app to support oncologist‑initiated genetic testing
This project tests a digital app (GA‑Mainstream) to help oncologists offer germline genetic testing to adults with breast, prostate, colon, or other GI cancers.
-
OCT-598 for advanced solid tumors
This trial tests whether OCT-598, by itself or with docetaxel, is safe and to find the best dose for adults with advanced solid tumors who have limited standard treatment options.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.